Startup Funding Tracker
Home›Companies›Biotech & Pharma›Aulos Bioscience

Aulos Bioscience, Inc.

Biotech & Pharma
Updated Oct 27, 2026·Latest SEC filing Aug 10, 2023·Suggest an edit

About Aulos Bioscience

Aulos Bioscience is a private company based in Larkspur, California, incorporated in 2020 in Delaware. It has reported $20,000,000 raised in two offerings on Form D since November 2020. Its chief executive is Aron Knickerbocker.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 28, 2023Aug 10, 2023$5,000,000of $20.0M target1$5.0MEquityRule 506(b)Form D ↗
Oct 30, 2020Nov 16, 2020$15,000,000of $40.0M target1$15.0MEquityRule 506(b)Form D ↗
Total, two offerings$20,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aulos Bioscience's Form D filed Aug 10, 2023.

SH
Seth Harrison
Director
First appears on the Form D that Aulos Bioscience filed on August 10, 2023; on 1 of its 2 filings.
Seth Harrison appears on 9 Form D filings at 6 companies:
  • Nine Square Therapeutics, director: Jul 1, 2020 · Feb 3, 2021 (amended)
  • Initial Therapeutics, director: Jul 16, 2020 · Feb 4, 2021 (amended)
  • Replicate Bioscience, director: Feb 16, 2021 · Mar 9, 2022 (amended)
  • Red Queen Therapeutics, director: Nov 2, 2021
  • Deep Apple Therapeutics, director: Dec 22, 2021
  • Aulos Bioscience, director: Aug 10, 2023
RC
Rajesh Chopra
Director
On every Form D that Aulos Bioscience has filed: 2 filings, from Nov 16, 2020 to Aug 10, 2023.
Rajesh Chopra appears on 4 Form D filings at 2 companies:
  • Initial Therapeutics, director: Jul 16, 2020 · Feb 4, 2021 (amended)
  • Aulos Bioscience, director: Nov 16, 2020 · Aug 10, 2023
AB
Anna Batarina
Director
First appears on the Form D that Aulos Bioscience filed on August 10, 2023; on 1 of its 2 filings.
AK
Aron Knickerbocker
CEO and President, director
First appears on the Form D that Aulos Bioscience filed on August 10, 2023; on 1 of its 2 filings.
JV
James Vasselli
Executive officer
First appears on the Form D that Aulos Bioscience filed on August 10, 2023; on 1 of its 2 filings.
ME
Michael Ehlers
Director
On every Form D that Aulos Bioscience has filed: 2 filings, from Nov 16, 2020 to Aug 10, 2023.
Michael Ehlers appears on 9 Form D filings at 5 companies:
  • Nine Square Therapeutics, director: Jul 1, 2020 · Feb 3, 2021 (amended)
  • Initial Therapeutics, director: Jul 16, 2020 · Feb 4, 2021 (amended)
  • Aulos Bioscience, director: Nov 16, 2020 · Aug 10, 2023
  • Replicate Bioscience, executive officer and director: Feb 16, 2021 · Mar 9, 2022 (amended)
  • Deep Apple Therapeutics, director: Dec 22, 2021
MR
Mace Rothenberg
Director
First appears on the Form D that Aulos Bioscience filed on August 10, 2023; on 1 of its 2 filings.
YO
Yanay Ofran
Director
On every Form D that Aulos Bioscience has filed: 2 filings, from Nov 16, 2020 to Aug 10, 2023.
LR
Leo Redmond
Executive officer
First appears on the Form D that Aulos Bioscience filed on August 10, 2023; on 1 of its 2 filings.

Earlier filings also listed

  • Yechezkel Barenholz · director
    Last listed on the Form D that Aulos Bioscience filed on November 16, 2020; on 1 of its 2 filings.
  • Micah Pearlman · executive officer
    Last listed on the Form D that Aulos Bioscience filed on November 16, 2020; on 1 of its 2 filings.
  • Joseph Yanchik · director
    Last listed on the Form D that Aulos Bioscience filed on November 16, 2020; on 1 of its 2 filings.
    Joseph Yanchik appears on 3 Form D filings at 2 companies:
    • Aulos Bioscience, director: Nov 16, 2020
    • Replicate Bioscience, director: Feb 16, 2021 · Mar 9, 2022 (amended)

Sources

  1. SECAulos Bioscience, Inc. filing history